Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: The invention relates to a bar lock for a locking system that is used, in particular, in metal cabinet doors. Said locking system comprises a lock body (10) and a pinion (18), which is mounted therein and which is provided for actuating the lock bars (12) reaching through the lock body (10). The invention is characterized in that two pinions (18), which are connected to one another with positive fit, are placed inside the one-piece lock body (10), and the engaging openings, which are formed on the lock bars (12) and provided for the teeth (19) of the pinion (18), are provided in the form of laterally open denticulations (29) and as perforations (30).

Abstract: Desoxypeganine and its pharmaceutically acceptable acid addition salts can be used in the treatment of drug addiction or drug dependence. Said substances are administered preferably in a continuos and controlled manner. The pharmaceutical administration form enables controlled release, e.g. for oral transdermal or another route of parenteral administration.

Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: Desoxypeganine and its pharmaceutically acceptable acid addition salts are useful in treating nicotine dependence.

Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: A casement closure device for a door is provided, and includes a housing adapted to be fixed to a door leaf or cabinet body. A key-operated lock cylinder is removably disposed in a channel of the housing. A locking tongue is held against the housing and is rotatable between an unlocking and a locking position. The lock cylinder is uncoupled from the locking tongue and is locked in the housing when a key is withdrawn from the lock cylinder. When a key is inserted and moved to the unlocking position, the lock cylinder is removable. The locking tongue is provided with an actuation opening adapted to positively engage an actuating unit insertable in the housing channel when the lock cylinder is removed from the housing.

Abstract: The invention relates to a device and method for the treatment of Alzheimer's dementia with desoxypeganine and/or a pharmaceutically acceptable acid addition salt of desoxypeganine.

Abstract: A bar-type closure for a door is provided. An actuating device is disposed on the outer surface of the door leaf and is rotatable between an opened and a closed position, with the rotational movement of the actuating device being convertible to longitudinal displacement of at least one locking rod that is guided parallel to the pivot axis of the door on the inner side of the door leaf thereof. The actuating device is provided with a hand lever that is pivotable outwardly about a hinge line axis oriented parallel to the pivot axis of the door and to the direction of displacement of the locking rod. The enlargement of the spacing between the hand lever and the door leaf, when the hand lever pivots, is converted into displacement of the locking rod into its release position by means of a Z-shaped drive lever that is disposed between the door leaf and the hand lever. One end of the drive lever is non-displaceably mounted in a first journal on an inner surface of the hand lever that faces the door leaf.

Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: The present invention describes a device for the controlled release of active compounds in the gastrointestinal tract with delayed pyloric passage, having a component expandable on contact with gastric juice, which is surrounded by a polymer covering which is permeable to gastric juice and active compounds. The device contains at least one active compound which is present in a multiparticulate preparation which releases the active compound into the gastric juice with a delay. Compared with conventional pharmaceutical forms with delayed pyloric passage, the release of active compound from a device according to the invention can be better controlled; likewise the device can be easily rolled or folded and can be introduced into capsules without problems.

Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.

Abstract: A device for the release of substances from pressure sensitive hot-melt adhesives with a uniform or non-uniform distribution of said substances is characterized by the fact that the pressure sensitive hot-melt adhesive is hydrophilic and comprises at least one water-soluble, or at least water-swellable, polymer, at least one water-soluble, meltable adhesive resin, as well as substance to be released.

Abstract: A sprayable, film-forming active substance preparation for the application to plants is characterized by the fact that films which can be produced thereof are pressure-sensitive adhesive, water-insoluble, and at least partially biodegradable.

Abstract: A process for the administration of a flowable solid, semisolid, or liquid medium exhibiting a controlled release of at least one active substance to plants by means of injection using needle-free, pressure-actuated devices is characterized in that the medium comprises active substance-containing microparticles of a maximum size of 100 .mu.m including the following components:a) 0.5-70%-wt. of at least one active substance,b) 10-70%-wt. of at least one biodegradable polymer,c) up to 20%-wt. of formulation adjuvants.

Abstract: Dimer alcohol bis-sulfates, trimer alcohol tris-sulfates and ether sulfates thereof are prepared by reacting dimer alcohols, trimer alcohols, or alkylene oxide adducts thereof with a sulfating agent, and then neutralizing the reaction product with an aqueous base material.

Abstract: Implantable, partially biodegradable, polymer-containing molded articles for the administration of active substances to plants are characterized by the fact that they comprise at least one hydrophobic polymer.

Abstract: A drug for the release of active substances to the skin, which has an increased deuterium portion as compared to the natural isotope distribution.